169 related articles for article (PubMed ID: 8691074)
21. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum.
Schlesinger LS; Horwitz MA
J Clin Invest; 1990 Apr; 85(4):1304-14. PubMed ID: 2138634
[TBL] [Abstract][Full Text] [Related]
22. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC
J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213
[TBL] [Abstract][Full Text] [Related]
23. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan.
Yan J; Vetvicka V; Xia Y; Hanikýrová M; Mayadas TN; Ross GD
Immunopharmacology; 2000 Jan; 46(1):39-54. PubMed ID: 10665778
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis.
Detmers PA; Powell DE; Walz A; Clark-Lewis I; Baggiolini M; Cohn ZA
J Immunol; 1991 Dec; 147(12):4211-7. PubMed ID: 1721641
[TBL] [Abstract][Full Text] [Related]
25. [CR1(immune adherence receptor), CR2(EB virus receptor), CR3(Mac-1, CD11b/CD18), CR4(CD11c/CD18)].
Wakasa K; Seya T
Nihon Rinsho; 2010 Jun; 68 Suppl 6():68-72. PubMed ID: 20942004
[No Abstract] [Full Text] [Related]
26. Inhibition by monoclonal anticomplement receptor type 1 on interactions between senescent human red blood cells and monocytic-macrophagic cells.
Gattegno L; Saffar L; Vaysse J
J Leukoc Biol; 1989 May; 45(5):422-8. PubMed ID: 2708912
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.
Delibrias CC; Kazatchkine MD; Fischer E
Scand J Immunol; 1993 Aug; 38(2):183-9. PubMed ID: 8346417
[TBL] [Abstract][Full Text] [Related]
28. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
[TBL] [Abstract][Full Text] [Related]
29. Phagocytosis of serum-opsonized zymosan down-regulates the expression of CR3 and FcRI in the membrane of human monocytes.
Wolf HM; Mannhalter JW; Salzmann HC; Göttlicher J; Ahmad R; Eibl MM
J Immunol; 1988 Nov; 141(10):3537-43. PubMed ID: 2972775
[TBL] [Abstract][Full Text] [Related]
30. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18).
Roubey RA; Ross GD; Merrill JT; Walton F; Reed W; Winchester RJ; Buyon JP
J Immunol; 1991 May; 146(10):3557-62. PubMed ID: 1673986
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3.
Krauss JC; PooH ; Xue W; Mayo-Bond L; Todd RF; Petty HR
J Immunol; 1994 Aug; 153(4):1769-77. PubMed ID: 8046243
[TBL] [Abstract][Full Text] [Related]
32. Modulation in the expression of type 1 (CR1/CD35) and type 3 (CR3/CD11b) complement receptors on leukocytes from patients with Visceral leishmaniasis.
Campelo CM; Pinheiro IC; de Melo Tavares B; Alves de Lima Henn G; Fernandes C; Albuquerque-Pinto LC; Carneiro Câmara LM
Exp Parasitol; 2020 Nov; 218():107970. PubMed ID: 32828829
[TBL] [Abstract][Full Text] [Related]
33. Pre-ligation of CR1 enhances IgG-dependent phagocytosis by cultured human monocytes.
Waytes AT; Malbran A; Bobak DA; Fries LF
J Immunol; 1991 Apr; 146(8):2694-700. PubMed ID: 1826698
[TBL] [Abstract][Full Text] [Related]
34. Participation of CR1 (CD35), CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in membranoproliferative glomerulonephritis type I.
Soma J; Saito T; Seino J; Sato H; Ootaka T; Yusa A; Abe K
Clin Exp Immunol; 1995 May; 100(2):269-76. PubMed ID: 7743666
[TBL] [Abstract][Full Text] [Related]
35. Markers of inflammatory activation: upregulation of complement receptors CR1 and CR3 on synovial fluid neutrophils from patients with inflammatory joint disease.
Crockard AD; Thompson JM; McBride SJ; Edgar JD; McNeill TA; Bell AL
Clin Immunol Immunopathol; 1992 Nov; 65(2):135-42. PubMed ID: 1395130
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils.
Neuman E; Huleatt JW; Jack RM
J Immunol; 1990 Nov; 145(10):3325-32. PubMed ID: 1977799
[TBL] [Abstract][Full Text] [Related]
37. Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1.
Bouhlal H; Galon J; Kazatchkine MD; Fridman WH; Sautès-Fridman C; Haeffner Cavaillon N
J Immunol; 2001 Mar; 166(5):3377-83. PubMed ID: 11207294
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.
Amdahl H; Haapasalo K; Tan L; Meri T; Kuusela PI; van Strijp JA; Rooijakkers S; Jokiranta TS
PLoS One; 2017; 12(3):e0172675. PubMed ID: 28273167
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1).
Bussolino F; Fischer E; Turrini F; Kazatchkine MD; Arese P
J Biol Chem; 1989 Dec; 264(36):21711-9. PubMed ID: 2600088
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3.
Bartók I; Walport MJ
J Immunol; 1995 May; 154(10):5367-75. PubMed ID: 7730637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
